Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 6, 2015, Pages

  Mccleery, Jenny ^a   Morgan, Shirlony ^b   Bradley, Kevin M ^c   Noel Storr, Anna H ^d   Ansorge, Olaf ^e   Hyde, Chris ^f  

^a OXFORD HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE I 123; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; RADIOACTIVE IODINE; TROPANE DERIVATIVE;

AGE; ALZHEIMER DISEASE; AUTOPSY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; FALSE POSITIVE RESULT; HUMAN; NEUROPATHOLOGY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SYSTEMATIC REVIEW; BRAIN; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; PATHOLOGY;

ALZHEIMER DISEASE; BRAIN; DIAGNOSIS, DIFFERENTIAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IODINE RADIOISOTOPES; LEWY BODY DISEASE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 84957105770     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010633.pub2     Document Type: Review

References (32)

1. Walker RWH, Walker Z. Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies. Movement Disorders 2009;24(Suppl2):S754-9.
2. Walker Z, Costa DC, Walker RWH, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. Journal of Neurology, Neurosurgery, and Psychiatry 2002;73(2):134-40.
3. Walker Z, Jaros E, Walker RWH, Lee L, Costa DC, Livingston G, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. Journal of Neurology, Neurosurgery, and Psychiatry 2007;78(11):1176-81.
4. Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, et al. Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease. Annals of Neurology 2004;55(6):774-80.
5. Lim SM, Katsifis A, Villemagne VL, Best R, Jones G, Saling M, et al. The 18F-FDG PET cingulate island sign and comparison to 123I-β-CIT SPECT for diagnosis of dementia with Lewy bodies. Journal of Nuclear Medicine 2009;50(10):1638-45.
6. Perju-Dumbrava L, Kovacs GG, Jellinger K, Schmidbauer M, Hoffmann M, Asenbaum S, et al. DAT SPECT in post mortem-confirmed Parkinsonian disorders. European Journal of Neurology Conference: 13th Congress of the EFNS. Florence, 2009.
7. Colloby SJ, McParland S, O'Brien JT, Attems J. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain 2012;135:2798-808.
8. Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, et al. Neuroleptic sensitivity in Parkinson's disease and Parkinsonian dementias. Journal of Clinical Psychiatry 2005;66(5):633-7.
9. Aarsland D. Early discriminatory diagnosis of dementia with Lewy bodies: The emerging role of CSF and imaging biomarkers. Dementia and Geriatric Cognitive Disorders 2008;25:195-205.
10. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 2003;24(2):197-211.
11. Ceravolo R, Volterrani D, Gambaccini G, Rossi C, Logi C, Manca G, et al. Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease. Neurological Sciences 2003;24:162-3.
12. 123I-labelled dopamine transporter ligands, version 2. European Journal of Nuclear Medicine & Molecular Imaging 2010;37(2):443-50.
13. Dickson JC, Tossici-Bolt L, Sera T, de Nijs R, Booij J, Bagnara MC, et al. Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database. European Journal of Nuclear Medicine & Molecular Imaging 2012;39(1):188-97.
14. 123I-Ioflupane SPECT. Journal of Nuclear Medicine 2012;53(1):154-63.
15. Heidebrink JL. Is dementia with Lewy bodies the second most common cause of dementia?. Journal of Geriatric Psychiatry and Neurology 2002;15:182-7.
16. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
17. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurology 2004;3:19-28.
18. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72.
19. McKeith I, O'Brien J, Walker Z, Tatsch K, Booji J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurology 2007;6:305-13.
20. Morgan S, Kemp P, Booij J, Costa DC, Padayachee S, Lee L, et al. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT. Journal of Neurology, Neurosurgery, and Psychiatry 2012;83(11):1063-70.
21. Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. Journal of Neurology 2010;257:359-66.
22. O'Brien JT, Colloby S, Fenwick J, WIlliams ED, Firbank M, Burn D, et al. Dopamine transporter loss visualised with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Archives of Neurology 2004;61(6):919-25.
23. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. Journal of Neurological Sciences 1990;95:119-39.
24. Reitsma JB, Rutjes AWS, Whiting P, Vlassov VV, Leeflang MMG, Deeks JJ. Chapter 9: Assessing methodological quality. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy, Version 1.0.0. The Cochrane Collaboration, 2009. Available from: http://srdta.cochrane.org/.
25. Rutjes AWS, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PMM. Case-control and two-gate designs in diagnostic accuracy studies. Clinical Chemistry 2005;51(8):1335-41.
26. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43.
27. Tatsch K. Imaging of the dopaminergic system in differential diagnosis of dementia. European Journal of Nuclear Medicine and Molecular Imaging 2008;35 Suppl 1:S51-7.
28. Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. European Journal of Nuclear Medicine and Molecular Imaging 2013;40(2):213-27.
29. Verghese J, Crystal HA, Dickson DW, Lipton RB. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 1999;53:1974-82.
30. Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. Journal of Neurology, Neurosurgery, and Psychiatry 2002;73:134-40.
31. Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: A revised tool for the quality assessment of diagnostic test accuracy studies. Annals of Internal Medicine 2011;155:529-36.
32. Zaccai J, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age and Ageing 2005;34:561-6.